HeraMED CEO David Groberman talks about the company’s progress
Finfeed
Archived
Dec 02, 2019
Medical technology group HeraMED Limited (ASX:HMD) has gone from strength to strength, excelling in the area of product development and distribution, but also forging alliances with other global, high profile medical institutions.